Single-cell transcriptomic profiling of epidermal growth factor receptor (EGFR)-mutant lung cancers reveals tumor-specific upregulation of BCL2L1 alongside downregulation of myeloid cell leukemia 1 (MCL1), a stoichiometric imbalance that buffers apoptotic susceptibility 57. Here, EGFR is linked to lung carcinoma.